
Valhi (VHI) Stock Forecast & Price Target
Valhi (VHI) Analyst Ratings
Bulls say
Valhi Inc is positioned for significant growth, with projected EBITDA increasing at a 37% compound annual growth rate (CAGR) from $25 million in FY25 to $47 million by FY27, accompanied by an improvement in EBITDA margin from 24.2% to 30.1% due to operating leverage. Additionally, the company anticipates a 23% increase in earnings per share (EPS) over the next 12 months, which surpasses the growth rates of similar peers in the Canadian software consolidation sector. This positive outlook is further supported by a strong performance in its Chemicals segment, particularly in the production of titanium dioxide, which is essential across multiple industries.
Bears say
Valhi Inc's financial outlook appears negative primarily due to a significant decline in revenue from its Attend Anywhere platform, which has faced a 57% decrease over the past two years, attributed to pricing pressures and competition from Microsoft Teams. Additionally, the NHS has reported a sustained decline in productivity, with estimates showing 2023/2024 productivity levels are 11% below those of 2019/2020, further complicating revenue generation in a key market. Furthermore, the company's EBITDA margin is projected to decrease from 26.4% in Q2/FY25 to 21.5% in Q3/FY25, revealing potential short-term financial strain despite a hoped-for recovery in subsequent quarters.
This aggregate rating is based on analysts' research of Valhi and is not a guaranteed prediction by Public.com or investment advice.
Valhi (VHI) Analyst Forecast & Price Prediction
Start investing in Valhi (VHI)
Order type
Buy in
Order amount
Est. shares
0 shares